-+ 0.00%
-+ 0.00%
-+ 0.00%

Interpace Biosciences holds annual stockholder meeting

PUBT·08/21/2026 10:02:13
Listen to the news
Interpace Biosciences holds annual stockholder meeting
  • Interpace Biosciences held its 2026 annual stockholders meeting on Aug. 20, 2026.
  • Stockholders adopted an amended and restated certificate of incorporation.
  • Investors authorized the board to amend the charter to execute a reverse stock split, if pursued, at a 1-for-2 to 1-for-10 ratio.
  • Approval was also secured for the 2026 Equity Incentive Plan.
  • Stockholders adopted the 2026 Employee Stock Purchase Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Interpace Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039530), on August 21, 2026, and is solely responsible for the information contained therein.